Table 7.
Treatmenta | P-value | ||||||
---|---|---|---|---|---|---|---|
Itemb | CON | CST | CHR | CST + CHR | CST | CHR | CST × CHR |
QG, % | |||||||
Prime | 0.18 | 0.89 | 0.16 | 0.16 | 0.12 | 0.09 | 0.11 |
Premium choice | 7.73 | 15.11 | 12.20 | 11.07 | 0.32 | 0.82 | 0.18 |
Choice | 43.02 | 39.43 | 51.48 | 46.56 | 0.40 | 0.13 | 0.90 |
Select | 48.98 | 42.79 | 33.68 | 40.93 | 0.88 | 0.09 | 0.19 |
Standard | 0.05 | 0.68 | 1.42 | 0.68 | 0.54 | 0.28 | 0.28 |
YG, % | |||||||
1c | 1.14b | 7.69a | 10.23a | 4.55ab | 0.18 | 0.05 | <0.01 |
2 | 36.48 | 25.36 | 27.21 | 38.01 | 0.95 | 0.72 | 0.03 |
3 | 47.51 | 44.96 | 40.97 | 46.43 | 0.77 | 0.62 | 0.43 |
4 or 5 | 13.12ab | 17.00a | 16.87a | 7.76b | 0.33 | 0.32 | 0.05 |
Liver score, % | |||||||
Edible | 81.58 | 89.58 | 88.19 | 82.16 | 0.78 | 0.87 | 0.08 |
Abnormal | 16.41 | 9.53 | 10.94 | 14.58 | 0.65 | 0.98 | 0.15 |
Lung consolidation scored, % | |||||||
1 | 15.18 | 12.03 | 14.24 | 12.96 | 0.53 | 0.99 | 0.79 |
2 | 4.43 | 7.50 | 6.58 | 6.59 | 0.53 | 0.75 | 0.53 |
3 | 2.84 | 1.73 | 2.66 | 0.86 | 0.25 | 0.59 | 0.65 |
Lung fibrin score, % | |||||||
Minor | 9.99 | 6.99 | 14.29 | 13.36 | 0.49 | 0.11 | 0.65 |
Extensive | 11.00 | 9.34 | 11.72 | 9.46 | 0.53 | 0.90 | 0.93 |
Lung status, % | |||||||
Normal | 42.32 | 48.42 | 34.93 | 38.84 | 0.38 | 0.14 | 0.87 |
Abnormal | 44.75 | 40.17 | 50.49 | 46.47 | 0.39 | 0.23 | 0.95 |
Condemned | 10.00 | 9.74 | 13.44 | 13.59 | 0.98 | 0.33 | 0.95 |
aCON = placebo control; CST = 13 g per animal daily DM inclusion of Bacillus subtilis PB6 (CLOSTAT, Kemin Industries, Des Moines, IA); CHR = 450 ppb DM chromium propionate (KemTRACE Chromium, Kemin Industries); CST + CHR = 13 g per animal daily DM inclusion of Bacillus subtilis PB6 + 450 ppb DM chromium propionate.
bLS means without common superscript differ (P ≤ 0.05).
cDue to low frequency of YG 1, means presented are calculated rather than least square means.
dLung consolidation score parameters are as follows: 1 = 0–15% consolidation of tissue or mycoplasma-like lesion; 2 = 15–50% consolidation of tissue or mycoplasma-like lesion; 3 = >50% consolidation of tissue or percentage of lung missing.